January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
LBL Biotech Inc.
LBL Biotech has developed a potential drug for treating several diseases including pancreatic cancer (PDAC), hepatoma (HCC), liver cirrhosis etc. Human clinical trial is in progress.